DEBRA FULLER: Open Payments
NPI 1093095663 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 28 payments from 10 companies in 2025. Trend: 2023 $609 · 2024 $832 · 2025 $1,149
Food & beverage: $1,050Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $644 |
| ABBVIE INC. | 10 | $192 |
| Novo Nordisk Inc | 2 | $123 |
| Pharmacosmos Therapeutics Inc. | 1 | $39 |
| ORPHALAN INC | 1 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Celltrion USA Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: TREMFYA, Wegovy, MAVYRET, RINVOQ, MONOFERRIC, CUVRIOR, CREON, ZENPEP.
Industry payments across WA — which companies pay providers there.
